Gyre Therapeutics, Inc. GYRE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s free cash flow?
- Gyre Therapeutics, Inc. (GYRE) reported free cash flow of $3M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s free cash flow changed year-over-year?
- Gyre Therapeutics, Inc.'s free cash flow increased by 1296.0% year-over-year, from -$251K to $3M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s free cash flow?
- Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s free cash flow has grown at a -82.2% compound annual growth rate (CAGR), from $5.69M to -$180K.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.